-
Mashup Score: 33Glioblastoma: Not Just Another Cancer - 6 day(s) ago
Summary:. This commentary urges a paradigm shift in how we approach research and drug development for glioblastoma, reimagining it as an aberrant brain-like organ, distinct from other cancers, to inspire innovative treatment strategies and interdisciplinary collaboration, addressing the minimal progress in extending glioblastoma patient survival despite years of research and investment.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 21Mayo Clinic expert describes 3 common brain tumors and their treatment - Mayo Clinic Comprehensive Cancer Center Blog - 29 day(s) ago
Neuro-oncologist Dr. Wendy Sherman gives an overview of meningioma, glioblastoma and secondary brain tumors.
Source: cancerblog.mayoclinic.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 26Tumor shrinkage in brain cancer patients renews optimism for CAR-T in solid malignancies - 2 month(s) ago
Last Updated 14 March 2024, 03:40 IST A breakthrough therapy that can cure blood cancer generated a dramatic response in brain cancer, rekindling optimism that the technique using a patient’s own immune system might help fight solid tumors. Tumors rapidly shrank within days in the first three glioblastoma patients who received the novel immunotherapy at Massachusetts General Hospital last spring. Although they eventually resumed growing, one patient’s cancer didn’t worsen for more than six months.
Source: www.deccanherald.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Living with Glioblastoma, with Rod Nordland - This Is Your Brain - 2 month(s) ago
New York Times journalist Rod Nordland is confronting his glioblastoma diagnosis with positivity, not despair. In this inspiring episode, he speaks with Dr. Stieg about coming to terms with the disease, what it’s like to live with his everyday challenges, and why he hasn’t shed a tear over it. Dr. Stieg: Hi, this is Dr. Phil
Source: thisisyourbrain.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 3Living with Glioblastoma, with Rod Nordland - This Is Your Brain - 2 month(s) ago
New York Times journalist Rod Nordland is confronting his glioblastoma diagnosis with positivity, not despair. In this inspiring episode, he speaks with Dr. Stieg about coming to terms with the disease, what it’s like to live with his everyday challenges, and why he hasn’t shed a tear over it. Dr. Stieg: Hi, this is Dr. Phil
Source: thisisyourbrain.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 2Rod Nordland: One of the Lucky Few | Neurological Surgery - 2 month(s) ago
When I first spoke to Rod Nordland about his diagnosis, I gave him the news as kindly and directly as I could. I do that with all my patients — I believe doctors should be honest as well as gentle when talking about a serious diagnosis. And Rod’s brain tumor was a glioblastoma multiforme (GBM), which is as serious as it gets, with a median survival time of about 15 months.
Source: neurosurgery.weillcornell.orgCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 2Rod Nordland: One of the Lucky Few | Neurological Surgery - 2 month(s) ago
When I first spoke to Rod Nordland about his diagnosis, I gave him the news as kindly and directly as I could. I do that with all my patients — I believe doctors should be honest as well as gentle when talking about a serious diagnosis. And Rod’s brain tumor was a glioblastoma multiforme (GBM), which is as serious as it gets, with a median survival time of about 15 months.
Source: neurosurgery.weillcornell.orgCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 21Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype - Journal of Neuro-Oncology - 2 month(s) ago
Introduction Recent studies have identified that glioblastoma IDH-wildtype consists of different molecular subgroups with distinct prognoses. In order to accurately describe and classify gliomas, the Visually AcceSAble Rembrandt Images (VASARI) system was developed. The goal of this study was to evaluate the VASARI characteristics in molecular subgroups of IDH-wildtype glioblastoma. Methods A…
Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 15Understanding current experimental models of glioblastoma-brain microenvironment interactions - 3 month(s) ago
Journal of Neuro-Oncology – Glioblastoma (GBM) is a common and devastating primary brain tumor, with median survival of 16–18 months after diagnosis in the setting of substantial resistance…
Source: link.springer.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 27Researchers discover early, promising glioblastoma treatment - 3 month(s) ago
A team of Michigan State University scientists has unveiled a potential game-changer in the fight against glioblastoma, the most common and currently incurable form of brain cancer.
Source: medicalxpress.comCategories: General Medicine News, General HCPsTweet
Read a Special Commentary from the April issue— #Glioblastoma: Not Just Another Cancer, by Howard Fine. https://t.co/hhrnCjpbFX @WeillCornell @WCMCNeurology https://t.co/2h8D0aUipw